Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Combined HIV prevention in female cis and trans sex workers: Clinical experience with PrEP, PEP and a comprehensive approach in an STI clinic.

Created on 18 Sep 2026

Authors

Beatriz Pérez-Monte Mínguez, Maria Teresa Filigheddu, Carlos Sanz Sánchez, Fátima Rico Bazago, Oriol Martín Segarra, Juan Emilio Losa García

Published in

Enfermedades infecciosas y microbiologia clinica (English ed.). Pages 503267. Sep 17, 2026. Epub Sep 17, 2026.

Abstract

Implementing PrEP and PEP among cis and trans female sex workers remains a challenge, representing an underrepresented population in prevention programs in Spain.
Retrospective descriptive study of HIV-negative cis and trans female sex workers managed at a Madrid clinic (December 2024-August 2025; n = 34).
Most (85.3%) were cis women (median age: 28 years); 85.3% were of Latin American origin and 88.2% had an irregular administrative status. Baseline STI prevalence was 32.4%, with low prior screening (20.6%). PEP was received by 16 patients (47.1%), and 9 transitioned to PrEP. PrEP was initiated by 17 patients (50.0%); 6 (35.3%) discontinued, primarily due to gastrointestinal intolerance within the first weeks. Vaccination reached 70.6% (24 patients).
PEP was associated with significant PrEP uptake. High early discontinuation rates highlight the need to optimize follow-up and suggest long-acting injectable formulations as a strategic alternative for this vulnerable population.

PMID:
42754467
Bibliographic data and abstract were imported from PubMed on 18 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement